$0.1470
-0.0102-6.49%
Last update: Nov 12, 7:21 PM
Senti Biosciences Holdings Inc
SNTINASDAQ
Senti Biosciences fell 91.8% from $1.79 to $0.15, behind the S&P 500's +12.7%. Its worst day was Jul 15 (−39.7%), and its low came Nov 10 at $0.14.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.69 missed the $-0.58 estimate on $0.00 revenue (est. $166,670.00).
−10.1% · S&P 500 0.0%
Senti Biosciences closed at its highest level of the year, 33.5% above where the year started.
Story events cover the past 12 months · Times ET
+12.2% · S&P 500 −0.3%
EPS of $-0.53 missed the $-0.46 estimate on $22,000.00 revenue (est. $500,000.00).
−10.4% · S&P 500 −1.7%
EPS of $-0.14 beat the $-0.34 estimate on $16,000.00 revenue.
+8.0% · S&P 500 +0.8%
Senti Biosciences shares rose 16.8%, while the S&P 500 fell 0.0%.
+16.8% · S&P 500 0.0%
Senti Biosciences shares fell 39.7%, while the S&P 500 rose 0.4%.
−39.7%, the year's worst day · S&P 500 +0.4%
EPS of $-0.41 missed the $-0.28 estimate on $17,000.00 revenue.
−4.2% · S&P 500 −0.5%
Senti Biosciences shares fell 20.0%, while the S&P 500 fell 0.0%.
−20.0% · S&P 500 0.0%
Senti Biosciences shares fell 23.9%, while the S&P 500 fell 1.8%.
−23.9% · S&P 500 −1.8%
Where it ended: a close of $0.15 on Nov 12, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.31).
Nothing in the past 12 months.
All SNTI dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SNTI and SPY from Benzinga historical bars. Not investment advice.
